通过FXR介导的抗原特异性CD8+ T细胞在肝脏内胆管癌中增强抗瘤免疫力

Shanshan Liu1, Zhixing Liang2, Lisi Zhu1

  • 1Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.

PubMed
概括

法尔内索伊德X受体 (FXR) 驱动CD8+T细胞在肝脏内胆管癌 (ICC) 中的耗尽. 用ursodeoxycholic acid (UDCA) 抑制FXR可以恢复T细胞功能,并增强ICC的免疫疗法.